Correlation Between Edgewise Therapeutics and Intellia Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Intellia Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Intellia Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Intellia Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Edgewise and Intellia is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Intellia Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Intellia Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Intellia Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 1.75 times less risky than Intellia Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Intellia Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 950.00 in Intellia Therapeutics on November 18, 2024 and sell it today you would earn a total of 120.00 from holding Intellia Therapeutics or generate 12.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Intellia Therapeutics
Performance |
| Timeline |
| Edgewise Therapeutics |
| Intellia Therapeutics |
Edgewise Therapeutics and Intellia Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Intellia Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |